Topic: mrna-lnp vaccine

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce a suite of comprehensive mRNA-LNP Vaccine Laboratory Process Development Assays. This latest addition to CD Bioparticles’ extensive service portfolio is specifically designed for the rapid and efficient development of mRNA-LNP vaccines. The mRNA molecule is well known to the public through COVID-19 and the mRNA vaccine made from it is characterized by rapid blocking of ...